PROS1-induced reduction of epithelial-driven inflammation and promotion of epithelial barrier repair, combined with reduction of myeloid-driven coagulation and complement pathways and efficient antigen presentation, may all combine to determine a mild COVID-19 phenotype. Here, PROS1 is linked to COVID-19.